Form 4: Dare Bioscience Director Receives Restricted Stock Units

Dare Bioscience, Inc. reports that Director William H. Rastetter was granted restricted stock units (RSUs) as compensation for board services.

Summary

• William H. Rastetter, a Director at Dare Bioscience, Inc., received 38,862 restricted stock units (RSUs) on June 30, 2026.
• These RSUs were granted in lieu of cash compensation for his services on the issuer's board of directors and its committees.
• The RSUs vest on January 4, 2027, and each RSU represents a contingent right to receive one share of common stock upon vesting.
• Following this transaction, Mr. Rastetter beneficially owns 39,721 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation event for a director and does not indicate significant new financial performance or strategic shifts.

Positives

• Director compensation is being provided through equity, aligning incentives with shareholders.
• The company is utilizing a mechanism (RSUs) to compensate board members for their services.

Future Outlook

The RSUs granted will vest on January 4, 2027, at which point the reporting person will be entitled to receive shares of common stock.

Industry Context

StockSavvy.ai notes that the use of Restricted Stock Units (RSUs) for director compensation is a common practice in the biotechnology and pharmaceutical sectors, aiming to retain experienced board members and align their interests with long-term company performance.

Related Party Transactions

• Grant of 38,862 restricted stock units to Director William H. Rastetter in lieu of cash compensation for board services.

Stakeholder Impact

• Shareholders: The issuance of RSUs dilutes ownership slightly but aligns director compensation with long-term stock performance.
• Employees: No direct impact mentioned.
• Management: Standard compensation practice for board members.
• Creditors: No direct impact mentioned.

Next Steps

• Vesting of RSUs on January 4, 2027.

Key Dates

Keywords

Dare Bioscience, DARE, Form 4, SEC Filing, Director Compensation, Restricted Stock Units, RSUs, Beneficial Ownership, William H. Rastetter